April 12, 2023
Cannabis stocks have largely been a losing proposition after the heady days that followed the full legalization in Canada back in 2018.
Even with another spike in the post-COVID euphoria that saw most risky assets rise dramatically in price — like crypto and meme stocks — the cannabis sector has lost over 80% of its value by market capitalization since peaking in summer of 2018.
You can see that below in the chart of the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) and the Horizons US Marijuana Index ETF (TSX: HMUS).
Check out our latest free research reports for in depth analysis on specific market trends. View Reports
I reference Canadian cannabis ETFs first because it was legalized federally there first and because the stocks have been trading longer on major Canadian stock exchanges.
Cannabis stock ETFs didn’t debut until later in the United States, likely because of the fractured legal framework where cannabis can be legal at the state level but is still illegal federally.
As of early 2023, cannabis companies can only list on major US exchanges like the NYSE and NASDAQ if they operate exclusively outside the country. If a cannabis stock operates in the US it has to list over-the-counter (OTC).
Funds that own US cannabis operators, however, have been able to list on major exchanges. The most well known and liquid, probably because it was the first, is the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS). It listed in 2020 and is down more than 80% from its peak in early 2021.
Top Five Cannabis Stock Holdings
An easy way to get a look at the top cannabis stocks is to look at what those cannabis ETFs are holding.
The top five holdings of the AdvisorShares Pure US Cannabis ETF, which together make up more than 75% of the fund, are:
- Green Thumb Industries (OTC: GTBIF)
- Curaleaf Holdings (OTC: CURLF)
- Trulieve Cannabis (OTC: TCNNF)
- Verano Holdings (OTC: VRNOF)
- Cresco Labs (OTC: CRLBF)
On the Canadian side, the top five holdings of the Horizons Marijuana Life Sciences Index ETF, which make up two thirds of the fund, are:
- Jazz Pharmaceuticals (NASDAQ: JAZZ)
- Scotts Miracle-Gro (NYSE: SMG)
- Innovative Industrial Properties (NYSE: IIPR)
- Cronos Group (NASDAQ: CRON)
- Tilray Brands (NASDAQ: TLRY)
While there are hundreds of cannabis stocks in the US and Canada, the ten outlined above would be a great starting point for most investors interested in building their own cannabis stock portfolio.
Check out our premium publications for more trading recommendations and exclusive coverage on the markets. View Publications
Legal Status of Cannabis at the State and Federal Level
Cannabis is currently legal for recreational use in 21 states in the US, as well as in Washington DC and Guam, as of early 2023. Minnesota and Ohio are considering passing bills that would legalize marijuana this year. A ballot measure in Oklahoma to make cannabis legal there failed in March 2023.
Thirty-nine (39) states have legalized it for medical use.
While President Biden has said he will issue pardons to those convicted federally of marijuana possession, it remains illegal at the federal level, and the efforts to pass meaningful legislation in Congress have routinely passed the House but failed in the Senate.
The most-watched bill is the Secure and Fair Enforcement (SAFE) Banking Act. The bill wouldn’t legalize cannabis at the federal level, but it would prohibit a federal banking regulator from penalizing a depository institution for providing banking services to a legitimate cannabis-related business. Full legalization likely wouldn’t be far behind if it passes.
But the bill has been around in different forms since 2019, and has yet to make it through the Senate, despite Senate Majority Leader Chuck Shumer saying it was “very close” in October 2022 and despite polls showing voters support it by a 57% margin.
Even Treasury Secretary Janet Yellen has said that the Treasury is supportive of the banking legislation.
But with the recent bank failures and looming debt ceiling, it looks like any cannabis legislation in the Senate will be put on the back burner once again.
And don’t count on it happening via an executive order, as White House Press Secretary Karine Jean-Pierre said in January 2023 that the ball is in Congress’s court, with no current plans for administrative action to resolve the issue.
Cannabis Stock Performance & Outlook
Cannabis stocks trade as a group, moving in lock-step to positive and negative news on the legislative and pricing front.
As mentioned above, the news has mostly been negative for the past few years with no movement on US federal cannabis legislation and a decline in cannabis prices.
According to Statistics Canada, a gram of legal cannabis costs $10.29 on average in 2019, the year after recreational cannabis was legalized in Canada. Legal weed prices have fallen dramatically in recent years, with the Ontario Cannabis Store advertising several brands of flower for between $3.50 and $4.50 per gram in recent months.
This makes investing in cannabis stocks a game of timing. There will need to be meaningful legislation in the US before cannabis stocks can get bullish again.
Advice for Investing in Cannabis
My two cents is that as of now, most investors should probably stay away from cannabis stocks. However, if you're determined to get in on the game, there's no harm in putting a small percentage of your portfolio in one of the cannabis stock ETFs like HMMJ or HMUS.
The cannabis ETFs are the safest way to invest in the sector, and you'll still get the boost when good news on the cannabis front does come, without having to pick between the hundreds of individual stocks.
For those more adventurous investors willing to take on the risk of investing in individual stocks, the several cannabis ETF holdings listed above are a great place to start.
Publisher, Daily Profit Cycle